These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 25597559)

  • 21. Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention.
    Peterson GM; Boom K; Jackson SL; Vial JH
    Intern Med J; 2002; 32(1-2):15-23. PubMed ID: 11783668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the Appropriateness of Oral Anticoagulation for Atrial Fibrillation in Advanced Frailty: Use of Stroke and Bleeding Risk-Prediction Models.
    O'Caoimh R; Igras E; Ramesh A; Power B; O'Connor K; Liston R
    J Frailty Aging; 2017; 6(1):46-52. PubMed ID: 28244558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decision making for oral anticoagulants in atrial fibrillation: the ATA-AF study.
    Gussoni G; Di Pasquale G; Vescovo G; Gulizia M; Mathieu G; Scherillo M; Panuccio D; Lucci D; Nozzoli C; Fabbri G; Colombo F; Riva L; Baldo CI; Maggioni AP; Mazzone A;
    Eur J Intern Med; 2013 Jun; 24(4):324-32. PubMed ID: 23684591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly.
    McCrory DC; Matchar DB; Samsa G; Sanders LL; Pritchett EL
    Arch Intern Med; 1995 Feb; 155(3):277-81. PubMed ID: 7832599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Underuse of Anticoagulation in Older Patients with Atrial Fibrillation and CHADS
    Henrard S; Vandenabeele C; Marien S; Boland B; Dalleur O
    Drugs Aging; 2017 Nov; 34(11):841-850. PubMed ID: 29086350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.
    McGrath ER; Go AS; Chang Y; Borowsky LH; Fang MC; Reynolds K; Singer DE
    J Am Geriatr Soc; 2017 Feb; 65(2):241-248. PubMed ID: 28039855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and antithrombotic management of atrial fibrillation in hospitalised patients.
    Berti D; Moors E; Moons P; Heidbuchel H
    Heart; 2015 Jun; 101(11):884-93. PubMed ID: 25872523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation: FANTASIIA Study.
    Moreno-Arribas J; Bertomeu-González V; Anguita-Sanchez M; Cequier Á; Muñiz J; Castillo J; Sanchis J; Roldán I; Marín F; Bertomeu-Martínez V;
    J Cardiovasc Pharmacol Ther; 2016 Mar; 21(2):150-6. PubMed ID: 26229096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulation prescription in atrial fibrillation.
    Bertomeu-González V; Cordero A; Mazón P; Moreno-Arribas J; Fácila L; Nuñez J; Rodríguez-Mañero M; Cosín-Sales J; González-Juanatey JR; Quiles J; Bertomeu-Martínez V;
    Expert Opin Pharmacother; 2011 Jul; 12(10):1473-9. PubMed ID: 21635195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.
    Olesen JB; Sørensen R; Hansen ML; Lamberts M; Weeke P; Mikkelsen AP; Køber L; Gislason GH; Torp-Pedersen C; Fosbøl EL
    Europace; 2015 Feb; 17(2):187-93. PubMed ID: 25236181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High rate of anticoagulation therapy in oldest old subjects with atrial fibrillation: the Octabaix study.
    Formiga F; Ferrer A; Mimbrera D; Badia T; Fernández C; Pujol R;
    J Am Med Dir Assoc; 2012 Jan; 13(1):8-10. PubMed ID: 21621470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The atrial fibrillation in Turkey: Epidemiologic Registry (AFTER).
    Ertas F; Eren NK; Kaya H; Aribas A; Acar G; Kanadasi M; Gedik S; Oylumlu M; Yuksel M; Ulgen MS;
    Cardiol J; 2013; 20(4):447-52. PubMed ID: 23677730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics.
    Choudhry NK; Soumerai SB; Normand SL; Ross-Degnan D; Laupacis A; Anderson GM
    Am J Med; 2006 Jul; 119(7):607-15. PubMed ID: 16828633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An educational intervention on drug use in nursing homes improves health outcomes resource utilization and reduces inappropriate drug prescription.
    García-Gollarte F; Baleriola-Júlvez J; Ferrero-López I; Cuenllas-Díaz Á; Cruz-Jentoft AJ
    J Am Med Dir Assoc; 2014 Dec; 15(12):885-91. PubMed ID: 24895001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonadherence to guidelines for prescribing antiplatelet/anticoagulant therapy in patients with atrial fibrillation.
    Navarro-Juan M; Carbonell-Torregrosa MÁ; Palazón-Bru A; Martínez-Díaz AM; Gil-Guillén VF
    Fam Pract; 2016 Jun; 33(3):290-5. PubMed ID: 27006412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical, cognitive, and psychosocial conditions in relation to anticoagulation satisfaction among elderly adults with atrial fibrillation: The SAGE-AF study.
    Wang W; Saczynski J; Lessard D; Mailhot T; Barton B; Waring ME; Sogade F; Hayward R; Helm R; McManus DD
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2508-2515. PubMed ID: 31515920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for stroke and thromboprophylaxis in atrial fibrillation: what happens in daily clinical practice? The GEFAUR-1 study.
    Laguna P; Martn A; del Arco C; Gargantilla P;
    Ann Emerg Med; 2004 Jul; 44(1):3-11. PubMed ID: 15226703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of antithrombotic usage for atrial fibrillation in aged care facilities.
    Singh P; Arrevad PS; Peterson GM; Bereznicki LR
    J Clin Pharm Ther; 2011 Apr; 36(2):166-71. PubMed ID: 21366645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.